Naperville, IL, United States of America

Jasbir Singh

This inventor holds 29 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Inflammation Treatment. Top assignees: Decode Genetics Ehf, Biomarin Pharmaceutical Inc., Families of Spinal Muscular Atrophy. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jasbir Singh. Retrieved from https://idiyas.com/inventor/jasbir-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 7)

% Patents Active = 10.3

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 13)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 86(Granted Patents)

Company Filing History:

Biomarin Pharmaceutical Inc.

patents

3 out of 3

Families of Spinal Muscular Atrophy

patents

4. 2 out of 16,025

University of California

patents

5. 1 out of 26

Angion Biomedica Corporation

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

Histone Deacetylase Inhibitors

Inflammation

PDE4 Inhibitors

Spinal Muscular Atrophy

Nonsense Mutations

CNS Disorders

Cardiovascular Disorders

Small Molecule Modulators

Aryl Amino Acid Derivatives

Biaryl Heterocycles

Carboxylic Acid Derivatives

Cyclic Carboxylic Acids

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10981933 - Histone deacetylase inhibitors (2021-04-20),

2. 10526346 - Histone deacetylase inhibitors (2020-01-07),

3. 10301323 - Histone deacetylase inhibitors (2019-05-28),

4. 10287283 - Read-through compound prodrugs suppressing premature nonsense mutations (2019-05-14),

5. 10280182 - Histone deacetylase inhibitors (2019-05-07),

6. 10077260 - Read-through compound prodrugs suppressing premature nonsense mutations (2018-09-18),

7. 10059723 - Histone deacetylase inhibitors (2018-08-28),

8. 9908899 - Histone deacetylase inhibitors (2018-03-06),

9. 9540395 - Histone deacetylase inhibitors (2017-01-10),

10. 9512143 - Histone deacetylase inhibitors (2016-12-06),

11. 9067897 - 2,4-Diaminoquinazolines for spinal muscular atrophy (2015-06-30),

12. 8957066 - Histone deacetylase inhibitors (2015-02-17),

13. 8883833 - Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders (2014-11-11),

14. 8877816 - 4-(or 5-) substituted catechol derivatives (2014-11-04),

15. 8791267 - Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders (2014-07-29),

Title: Innovations and Contributions of Jasbir Singh in the Field of Biotechnology

Introduction

Jasbir Singh, based in Naperville, IL, is a renowned inventor with a prolific record of 29 patents to his name. His work primarily focuses on advancements in biotechnology, particularly in the development of histone deacetylase inhibitors which have significant implications for cancer therapies and other medical applications.

Latest Patents

Among his latest patents, Jasbir has made substantial contributions to the field with inventions related to histone deacetylase inhibitors. These inventions are crucial as they aim to inhibit histone deacetylase (HDAC) enzymes such as HDAC1, HDAC2, and HDAC3. By targeting these enzymes, his innovations hold great potential for altering gene expression to benefit therapeutic outcomes.

Career Highlights

Throughout his career, Jasbir has worked with esteemed organizations such as Decode Genetics and BioMarin Pharmaceutical Inc. His experience in these companies has enabled him to leverage his knowledge and skills in bringing groundbreaking inventions to fruition. He has developed a strong portfolio that showcases his dedication to advancing biotechnological research and its practical applications.

Collaborations

Jasbir's journey in the industry has allowed him to collaborate with notable professionals, including Mark E. Gurney and Vincent Premaratna Sandanayaka. These partnerships have fostered an environment of innovation, driving forward projects that push the boundaries of current scientific understanding and application.

Conclusion

In conclusion, Jasbir Singh’s extensive contributions to the field of biotechnology, particularly in the realm of histone deacetylase inhibitors, demonstrate his commitment to innovation. With a remarkable patent portfolio and influential collaborations, he continues to play a significant role in advancing medical science and improving therapeutic options for various diseases.

Profile summary based on public USPTO records.